- Home
- VALN vs CPAC Comparison
VALN vs CPAC Comparison
Compare VALN & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- CPAC
- Stock Information
- Founded
- VALN 2012
- CPAC 1949
- Country
- VALN France
- CPAC Peru
- Employees
- VALN N/A
- CPAC N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- CPAC Building Materials
- Sector
- VALN Health Care
- CPAC Industrials
- Exchange
- VALN Nasdaq
- CPAC Nasdaq
- Market Cap
- VALN 488.9M
- CPAC 494.0M
- IPO Year
- VALN 2021
- CPAC 2012
- Fundamental
- Price
- VALN $4.66
- CPAC $6.34
- Analyst Decision
- VALN Strong Buy
- CPAC Sell
- Analyst Count
- VALN 2
- CPAC 1
- Target Price
- VALN $18.50
- CPAC $6.00
- AVG Volume (30 Days)
- VALN 22.7K
- CPAC 14.1K
- Earning Date
- VALN 11-07-2024
- CPAC 10-29-2024
- Dividend Yield
- VALN N/A
- CPAC 8.54%
- EPS Growth
- VALN N/A
- CPAC 7.38
- EPS
- VALN N/A
- CPAC 0.12
- Revenue
- VALN $176,817,979.00
- CPAC $527,798,215.00
- Revenue This Year
- VALN $24.30
- CPAC N/A
- Revenue Next Year
- VALN $16.05
- CPAC N/A
- P/E Ratio
- VALN N/A
- CPAC $10.96
- Revenue Growth
- VALN N/A
- CPAC N/A
- 52 Week Low
- VALN $4.60
- CPAC $4.65
- 52 Week High
- VALN $12.85
- CPAC $6.65
- Technical
- Relative Strength Index (RSI)
- VALN 26.32
- CPAC 59.62
- Support Level
- VALN $4.63
- CPAC $6.23
- Resistance Level
- VALN $5.28
- CPAC $6.48
- Average True Range (ATR)
- VALN 0.18
- CPAC 0.25
- MACD
- VALN -0.09
- CPAC -0.00
- Stochastic Oscillator
- VALN 4.05
- CPAC 57.53
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.